Disease/Infection News

RSS

Pioneering diagnostics platform changes the way COVID-19 is detected

Montreal-based Two-Photon Research Inc. announces CAST, a diagnostics platform that changes the way viruses are detected. The CAST platform uses TPR’s patented Aptamer Molecular Photonic Beacon™ that photonically interfaces with smartphones.

10 Dec 2020

Study: TMEM41B transmembrane protein is a critical factor for SARS-CoV-2 replication

A single protein that appears necessary for the COVID-19 virus to reproduce and spread to other cells is a potential weakness that could be targeted by future therapies.

10 Dec 2020

Effective adoption of digital technology underpins businesses’ response to COVID-19

Increased adoption of new digital technology has underpinned businesses’ response to COVID-19, with four in ten citing it as both vital to retaining jobs, and the ongoing viability of their business model, according to a new report from the University of Liverpool.

10 Dec 2020

EKF launches high performance quantitative COVID-SeroKlir antibody test kit

EKF Diagnostics, the global in vitro diagnostics company, announces that it has introduced one of the first tests to precisely measure levels of COVID-19 neutralizing antibodies in individuals.

From EKF Diagnostics 10 Dec 2020

National lung health organizations urge universal vaccine adoption to end COVID-19 pandemic

As COVID-19 cases surge in the U.S., the nation is waiting for the availability of a safe and effective vaccine.

10 Dec 2020

Risk of COVID infection in health care workers is driven by community exposure

Nurses only group with higher risk once community exposure considered. Largest cohort of health care worker risk for SARS CoV-2. Only high-flow oxygen therapy and hemodialysis linked to more antibodies to SARS-CoV-2.

10 Dec 2020

Proactive management of COVID-19 risk can support employees' return to work

A Journal of Prevention, Assessment & Rehabilitation, published by IOS Press, is committed to helping organizations manage the challenges they face during the COVID-19 pandemic by publishing robust, evidence-based research, and commentary. All articles featured here and in the WORK COVID-19 Collection are freely available.

9 Dec 2020

Interim analysis of phase 3 study shows excellent efficacy of SARS-CoV-2 vaccine

South African study data were used to evaluate the safety of the vaccine in the results just published, but not its efficacy [which refers to the percentage reduction of disease].

9 Dec 2020

Researchers present new project for detection of SARS-COV-2 virus in indoor air

Researchers at the Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO) and the Universitat de València (UV) have presented the AIRCOV project for the detection of the SARS-COV-2 virus in indoor air.

9 Dec 2020

Toxin produced by E. coli bacteria also has nondiarrheal effects on the digestive tract

For people in wealthy countries, diarrhea is usually nothing more than an uncomfortable inconvenience for a few days. But for a poor child in a developing country, repeated bouts of diarrhea can lead to serious health consequences such as malnutrition, stunted growth and cognitive deficits.

9 Dec 2020

Researchers examine how COVID-19 face masks can be made more effective

Face masks are helpful in preventing the spread of COVID-19, but researchers believe they can be made even more effective, something that has implications far beyond the current pandemic as masks could become a more commonly used public health intervention.

9 Dec 2020

FDA approves first COVID-19 direct-to-consumer test

Today, the U.S. Food and Drug Administration authorized LabCorp's Pixel COVID-19 Test Home Collection Kit for use by any individual 18 years and older without a prescription.

9 Dec 2020

UCI researchers develop noninvasive, at-home saliva test to detect COVID-19

Researchers in the Henry Samueli School of Engineering at the University of California, Irvine announced promising results in the development of a noninvasive at-home antigen test to detect the spike of SARS-CoV-2 proteins in saliva.

9 Dec 2020

Study reveals COVID-19 outcomes for Californians with intellectual and development disabilities

A new study published recently in ScienceDirect by researchers from Syracuse University and SUNY Upstate Medical University shows that California residents who receive services for intellectual and development disabilities (IDD) have lower COVID-19 case rates but a higher case-fatality rate than the general population.

9 Dec 2020

Covid-19's impact on cancer services and research

The National Cancer Research Institute, Cancer Research UK and Public Health England's National Disease Registration Service hosted a Cancer/Covid-19 Research Summit with researchers from different disciplines discussing the impact that Covid-19 is having on cancer services and research.

9 Dec 2020

New guidelines improved the ability to predict C. diff infection mortality

Clostridioides difficile infection (CDI) is the most common health care-associated infection in the United States, causing an estimated 12,800 deaths each year.

9 Dec 2020

COVID-19 control measures reduce walking activities in United States

An international team of researchers has conducted a study demonstrating the effects that coronavirus disease 2019 (COVID-19) control measures have had on people’s walking patterns in the United States.

9 Dec 2020

Study suggests vast majority of Seattle population remains susceptible to COVID-19

Researchers in the United States have conducted a study suggesting that a small proportion of people living in Seattle were infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – by around late March/early April 2020.

9 Dec 2020

Virginia Tech researchers awarded NIH grant to develop Zika virus vaccine

Flaviviruses -- a group of viruses transmitted by ticks or mosquitoes -- infect an estimated 400 million people annually with diseases like yellow fever, Dengue fever, West Nile virus, and, most recently, Zika virus.

9 Dec 2020

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

A recent study by US researchers, currently available on the medRxiv preprint server, evaluated several cell-based assays that are under validation for determining correlates of protection in individuals with symptomatic coronavirus disease (COVID-19) and vaccine studies – and demonstrated their high concordance with both live and pseudotyped virions.

9 Dec 2020

Disease/Infection News

Pioneering diagnostics platform changes the way COVID-19 is detected

Study: TMEM41B transmembrane protein is a critical factor for SARS-CoV-2 replication

Effective adoption of digital technology underpins businesses’ response to COVID-19

EKF launches high performance quantitative COVID-SeroKlir antibody test kit

National lung health organizations urge universal vaccine adoption to end COVID-19 pandemic

Risk of COVID infection in health care workers is driven by community exposure

Proactive management of COVID-19 risk can support employees' return to work

Interim analysis of phase 3 study shows excellent efficacy of SARS-CoV-2 vaccine

Researchers present new project for detection of SARS-COV-2 virus in indoor air

Toxin produced by E. coli bacteria also has nondiarrheal effects on the digestive tract

Researchers examine how COVID-19 face masks can be made more effective

FDA approves first COVID-19 direct-to-consumer test

UCI researchers develop noninvasive, at-home saliva test to detect COVID-19

Study reveals COVID-19 outcomes for Californians with intellectual and development disabilities

Covid-19's impact on cancer services and research

New guidelines improved the ability to predict C. diff infection mortality

COVID-19 control measures reduce walking activities in United States

Study suggests vast majority of Seattle population remains susceptible to COVID-19

Virginia Tech researchers awarded NIH grant to develop Zika virus vaccine

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News